后生物作为性结肠炎的创新干预策略:对生物活性成分和作用机制的洞察
Tianxiang Xue1, Yanli Zhu1, Mengwei Chang1
1College of Food Science and Technology, Henan University of Technology, Zhengzhou, Henan 450001, China.
Journal of agricultural and food chemistry
|September 26, 2025
概括
后生物质药物通过影响肠道微生物群和免疫反应,对治疗性结肠炎 (UC) 有前途. 对其活性成分的进一步研究可能会导致肠道炎症的新疗法.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 性结肠炎 (UC) 涉及肠道炎症和屏障功能障碍.
- 后生物质越来越多地被认为是它们在调节肠道菌群和免疫力方面的作用.
- 在胃肠道疾病中,后生物作用的精确机制需要进一步阐明.
研究的目的:
- 审查有关后生物源和制备的文献.
- 讨论后生物活性成分在调节UC中的机制.
- 探索后生菌在控制肠道炎症和UC进展方面的潜力.
主要方法:
- 文献综述,重点关注后生物源,制备和机制.
- 对后生菌生物活性成分及其影响的研究分析.
- 检查参与UC后生物调节的途径.
主要成果:
- 后生物质会影响肠道屏障,微生物群和免疫代谢.
- 了解这些影响为操纵肠道炎症提供了洞察力.
- 后生物制品中的活性成分为UC提供了潜在的治疗途径.
结论:
- 后生物学为UC研究和治疗提供了一个新的视角.
- 对后生物机制的进一步研究可以推进治疗策略.
- 需要临床验证,但后生物学是UC管理的一个有希望的领域.
更多相关视频
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521
Inflammatory Bowel Disease V: Surgical Management
451
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
451
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
643
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
643
Drugs for Treatment of Ulcerative Colitis in IBD
460
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
460
Drugs for Treatment of Constipation-Predominant IBS
724
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
724
Peptic Ulcer Disease IV: Management
436
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
436


